GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (OTCPK:HLOSF) » Definitions » YoY EPS Growth

HLOSF (Healios KK) YoY EPS Growth : 100.00% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Healios KK YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Healios KK's YoY EPS Growth for the quarter that ended in Dec. 2024 was 100.00%.

Healios KK's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was $0.00.

Healios KK YoY EPS Growth Historical Data

The historical data trend for Healios KK's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healios KK YoY EPS Growth Chart

Healios KK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.52 15.39 23.11 41.96 20.26

Healios KK Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.93 -17.24 -125.58 47.95 100.00

Healios KK YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Healios KK's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(-0.311--0.39)/ | -0.39 |
=20.26 %

Healios KK's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(0--0.068)/ | -0.068 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healios KK YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Healios KK's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Healios KK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (OTCPK:HLOSF) » Definitions » YoY EPS Growth
Comparable Companies
TSE:4575 TSE:4599 TSE:7774 TSE:219A TSE:190A TSE:4978 TSE:4888 TSE:4894 TSE:4563 TSE:4880 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
4593:Japan 6VX:Germany
Address
World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115
Website
https://www.healios.co.jp
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.